InforMatrix as an alternative tool in rational and transparent drug-decision making

被引：7

作者：

Brenninkmeijer, Rob

Mairs, Jill

Timoney, Mark

Scott, Mike

McElnay, James

Janknegt, Robert ^{[1
]}

机构：

[1] Maasland Ziekenhuis, Dept Clin Pharm, Sittard, Netherlands

[2] Maasland Ziekenhuis, Dept Toxicol, Sittard, Netherlands

[3] No Hlth & Social Care Trust, Whiteabbey Hosp, Newtownabbey, North Ireland

[4] Dept Hlth Social Serv & Publ Safety, Belfast BT4 3SQ, Antrim, North Ireland

[5] Antrim Hosp, No Hlth & Social Care Trust, Belfast BT41 2RL, Antrim, North Ireland

[6] Sch Pharm, Ctr Med Biol, Belfast BT9 7BL, Antrim, North Ireland

[7] Digitalis BV, Amsterdam, Netherlands

来源：

EXPERT OPINION ON PHARMACOTHERAPY | 2007年 / 8卷

关键词：

drug selection; evidence based medicine; InforMatrix; matrix models;

D O I：

10.1517/14656566.8.S1.S31

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

InforMatrix is a decision matrix technique by means of which a group of experts on a subject (health condition) determine, on the basis of agreed criteria, an order of merit for the various available treatment options for that condition. The goal of the InforMatrix program is to make a rational selection of first-choice medications or drugs following the evaluation of the clinical value of available therapeutic agents. This paper describes the InforMatrix methodology, and also provides an explanation of the various selection criteria that are used by the InforMatrix technique of drug selection.

引用

页码：S31 / S36

页数：6

共 6 条

[1]

Brenninkmeijer R, 1994, PHARM WEEKBLAD, V129, P1185

[2] Triptans in the treatment of migraine: drug selection by means of the SOJA method [J].